PELL Bio-Med Technology Co (TPE:6949) Interest Expense: NT$-2.05 Mil (TTM As of Dec. 2025)


TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$925.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co Interest Expense?

PELL Bio-Med Technology Co TPE:6949 13 Interest Expense is NT$-2.05 Mil as of Dec. 2025. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PELL Bio-Med Technology Co's interest expense for the three months ended in Dec. 2025 was NT$ 2.31 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-2.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PELL Bio-Med Technology Co's Operating Income for the three months ended in Dec. 2025 was NT$ -174.17 Mil. PELL Bio-Med Technology Co's Interest Expense for the three months ended in Dec. 2025 was NT$ 2.31 Mil. PELL Bio-Med Technology Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PELL Bio-Med Technology Co  (TPE:6949) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PELL Bio-Med Technology Co's Interest Expense for the three months ended in Dec. 2025 was NT$2.31 Mil. Its Operating Income for the three months ended in Dec. 2025 was NT$-174.17 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2025 was NT$109.28 Mil.

PELL Bio-Med Technology Co's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

PELL Bio-Med Technology Co Interest Expense Historical Data

* Premium members only.

The historical data trend for PELL Bio-Med Technology Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co Interest Expense Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
-1.52 -1.36 -2.56 -2.26 -2.05

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.58 -1.46 -1.46 -1.43 2.31
TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of NT$-2.05 Mil mean?
PELL Bio-Med Technology Co (TPE:6949) has a Interest Expense of NT$-2.05 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on PELL Bio-Med Technology Co and its competitors.
Is PELL Bio-Med Technology Co's Interest Expense too high?
PELL Bio-Med Technology Co's current Interest Expense is NT$-2.05 Mil. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's Interest Expense compare to VRTX and REGN?
PELL Bio-Med Technology Co's Interest Expense of NT$-2.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on PELL Bio-Med Technology Co and its competitors. PELL Bio-Med Technology Co's current Interest Expense is NT$-2.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current Interest Expense of NT$-2.05 Mil. The current Interest Expense is NT$-2.05 Mil. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current Interest Expense is NT$-2.05 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$925.00
Price